Breaking News

Catalent Adds New Cryogenic Capabilities at Japanese Facility

Facility supports clinical supply demand for cell and gene therapy development.

Catalent, a company that enables the development and supply of better treatments for patients worldwide, expanded the services and capabilities at its facility in Shiga, Japan. The expansion will include the storage, kitting, and distribution of advanced therapies at ultra-low temperatures for clinical trials. State-of-the-art cryogenic freezers alongside material transfer equipment have been installed that are designed to retain the integrity of investigational advanced therapy products by m...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters